These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 9542187)

  • 1. [Lasers as an alternative to the endoscopic surgery in BPH].
    Rodrigo Aliaga M; Valls Blasco F; Jiménez Cruz JF
    Actas Urol Esp; 1998 Jan; 22(1):17-22. PubMed ID: 9542187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term results of contact laser versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia with small or moderately enlarged prostates.
    Tuhkanen K; Heino A; Aaltomaa S; Ala-Opas M
    Scand J Urol Nephrol; 2003; 37(6):487-93. PubMed ID: 14675922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of standard transurethral resection, transurethral vapour resection and holmium laser enucleation of the prostate for managing benign prostatic hyperplasia of >40 g.
    Gupta N; Sivaramakrishna ; Kumar R; Dogra PN; Seth A
    BJU Int; 2006 Jan; 97(1):85-9. PubMed ID: 16336334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The VLAP system (Visual Laser Ablation of the Prostate): comparative study of the contact versus non-contact techniques in a series of 100 cases].
    Breteau D; Koutani A; Albert P; Morin N; Salvo A
    Prog Urol; 1997 Apr; 7(2):235-9. PubMed ID: 9264765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective randomized trial comparing transurethral resection of the prostate and laser therapy in men with chronic urinary retention: The CLasP study.
    Gujral S; Abrams P; Donovan JL; Neal DE; Brookes ST; Chacko KN; Wright MJ; Timoney AG; Peters TJ
    J Urol; 2000 Jul; 164(1):59-64. PubMed ID: 10840425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised trial comparing holmium laser enucleation versus transurethral resection in the treatment of prostates larger than 40 grams: results at 2 years.
    Wilson LC; Gilling PJ; Williams A; Kennett KM; Frampton CM; Westenberg AM; Fraundorfer MR
    Eur Urol; 2006 Sep; 50(3):569-73. PubMed ID: 16704894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome.
    Bachmann A; Schürch L; Ruszat R; Wyler SF; Seifert HH; Müller A; Lehmann K; Sulser T
    Eur Urol; 2005 Dec; 48(6):965-71; discussion 972. PubMed ID: 16126327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years.
    Te AE; Malloy TR; Stein BS; Ulchaker JC; Nseyo UO; Hai MA
    BJU Int; 2006 Jun; 97(6):1229-33. PubMed ID: 16686717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of benign hyperplasia of the prostate using thermal transurethral needle ablation (TUNA)].
    Rodrígo Aliaga M; López Alcina E; Monserrat Monfort JJ; Pontones Moreno JL; Valls Blasco F; Boronat Tormo F; Jiménez Cruz JF
    Actas Urol Esp; 1997; 21(7):649-54. PubMed ID: 9412206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photoselective potassium titanyl phosphate (KTP) laser vaporization versus transurethral resection of the prostate for prostates larger than 70 mL: a short-term prospective randomized trial.
    Horasanli K; Silay MS; Altay B; Tanriverdi O; Sarica K; Miroglu C
    Urology; 2008 Feb; 71(2):247-51. PubMed ID: 18308094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial of safety and efficacy of transurethral resection of the prostate using contact laser versus electrocautery.
    Zorn BH; Bauer JJ; Ruiz HE; Thrasher JB
    Tech Urol; 1999 Dec; 5(4):198-201. PubMed ID: 10591258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective single-centre comparison of 120-W diode-pumped solid-state high-intensity system laser vaporization of the prostate and 200-W high-intensive diode-laser ablation of the prostate for treating benign prostatic hyperplasia.
    Ruszat R; Seitz M; Wyler SF; Müller G; Rieken M; Bonkat G; Gasser TC; Reich O; Bachmann A
    BJU Int; 2009 Sep; 104(6):820-5. PubMed ID: 19239441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of potassium-titanyl-phosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective non-randomized two-centre study.
    Ruszat R; Wyler SF; Seitz M; Lehmann K; Abe C; Bonkat G; Reich O; Gasser TC; Bachmann A
    BJU Int; 2008 Nov; 102(10):1432-8; discussion 1438-9. PubMed ID: 18671785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transurethral holmium laser enucleation of the prostate versus transurethral electrocautery resection of the prostate: a randomized prospective trial in 200 patients.
    Kuntz RM; Ahyai S; Lehrich K; Fayad A
    J Urol; 2004 Sep; 172(3):1012-6. PubMed ID: 15311026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the transurethral ethanol ablation of the prostate (TEAP) for symptomatic benign prostatic hyperplasia (BPH): a European multi-center evaluation.
    Grise P; Plante M; Palmer J; Martinez-Sagarra J; Hernandez C; Schettini M; Gonzalez-Martin M; Castiñeiras J; Ballanger P; Teillac P; Rolo F; Baena V; Erdmann J; Mirone V
    Eur Urol; 2004 Oct; 46(4):496-501; discussion 501-2. PubMed ID: 15363567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial comparing transurethral resection of the prostate, laser therapy and conservative treatment of men with symptoms associated with benign prostatic enlargement: The CLasP study.
    Donovan JL; Peters TJ; Neal DE; Brookes ST; Gujral S; Chacko KN; Wright M; Kennedy LG; Abrams P
    J Urol; 2000 Jul; 164(1):65-70. PubMed ID: 10840426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaporesection for managing benign prostatic hyperplasia using a 2-microm continuous-wave laser: a prospective trial with 1-year follow-up.
    Fu WJ; Hong BF; Yang Y; Zhang X; Gao JP; Zhang L; Wang XX
    BJU Int; 2009 Feb; 103(3):352-6. PubMed ID: 18778340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical impact of tamsulosin on generic and symptom-specific quality of life for benign prostatic hyperplasia patients: using international prostate symptom score and Rand Medical Outcomes Study 36-item Health Survey.
    Suzuki H; Yano M; Awa Y; Nakatsu H; Egoshi K; Mikami K; Ota S; Okano T; Hamano S; Ohki T; Furuya Y; Ichikawa T
    Int J Urol; 2006 Sep; 13(9):1202-6. PubMed ID: 16984553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experiences in the treatment of benign prostatic hyperplasia with high power potassium-titanyl-phosphate (KTP) laser].
    Lipiński MI; Peszyński-Drews C; Jeromin MZ; Jeromin LM
    Wiad Lek; 2006; 59(3-4):196-8. PubMed ID: 16813263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Benign prostatic hyperplasia: five year follow-up in patients who underwent contact laser vaporization].
    Vela Navarrete R; García Cardoso JV; Calahorra Fernández FJ; Rodríguez Miñón JL; Cabrera Pérez J; González Enguita C
    Arch Esp Urol; 2004 Mar; 57(2):131-4. PubMed ID: 15074782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.